Digoxin 250 microgram/ml solution for injection/infusion - Summary of Product Characteristics (SmPC) - print friendly - (emc)
![Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data | The BMJ Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data | The BMJ](https://www.bmj.com/sites/default/files/sites/defautl/files/attachments/bmj-article/2015/08/digoxin_tablets.jpg)
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data | The BMJ
![JCM | Free Full-Text | Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS) JCM | Free Full-Text | Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)](https://www.mdpi.com/jcm/jcm-11-01762/article_deploy/html/images/jcm-11-01762-g001.png)
JCM | Free Full-Text | Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)
![Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD, - ppt download Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD, - ppt download](https://slideplayer.com/slide/14566822/90/images/3/Background.jpg)
Digoxin And Mortality in Patients With Atrial Fibrillation With and Without Heart Failure: Does Serum Digoxin Concentration Matter? Renato D. Lopes, MD, - ppt download
![Digoxin, Inj 250 mcg/mL Injection, USP 2 mL Single Dose AmpuleInitial U.S. Approval: 1954These highlights do not include all the information needed to use digoxin safely and effectively. See full prescribing information Digoxin, Inj 250 mcg/mL Injection, USP 2 mL Single Dose AmpuleInitial U.S. Approval: 1954These highlights do not include all the information needed to use digoxin safely and effectively. See full prescribing information](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Image8.jpg&id=679226)
Digoxin, Inj 250 mcg/mL Injection, USP 2 mL Single Dose AmpuleInitial U.S. Approval: 1954These highlights do not include all the information needed to use digoxin safely and effectively. See full prescribing information
![Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study | European Journal of Hospital Pharmacy Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study | European Journal of Hospital Pharmacy](https://ejhp.bmj.com/content/ejhpharm/28/6/320/F1.large.jpg)
Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study | European Journal of Hospital Pharmacy
![Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation | Scientific Reports Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61065-4/MediaObjects/41598_2020_61065_Fig1_HTML.png)